Crysandt, Martina, Soysal, Hatice, Jennes, Eva, Holtick, Udo, Mrotzek, Matthias, Rehnelt, Susanne, Holderried, Tobias A. W., Wessiepe, Martina, Kunter, Uta, Wilop, Stefan, Silling, Gerda, Gecht, Judith, Beier, Fabian, Bruemmendorf, Tim H. and Jost, Edgar (2021). Selective ABO immunoadsorption in hematopoietic stem cell transplantation with major ABO incompatibility. Eur. J. Haematol., 107 (3). S. 324 - 333. HOBOKEN: WILEY. ISSN 1600-0609

Full text not available from this repository.

Abstract

Objective ABO mismatch between donor and recipient occurs in 40% of allogeneic hematopoietic stem cell transplantations (HCT). Different strategies have been described to reduce isohemagglutinins (IHA) before HCT. We describe the effect of selective ABO immunoadsorption (ABO IA) on erythrocyte transfusion rate and the development of post-transplant pure red cell aplasia (ptPRCA). Methods 63 patients with major ABO incompatibility were retrospectively analyzed. Nine patients with major ABO incompatibility and high-IHA titer were treated by ABO IA before HCT. We analyzed the need for transfusion and the occurrence of ptPRCA. We compared the outcome with patients treated by other methods to reduce IHA. Results In all nine patients treated by ABO IA, IHA decreased in a median four times. PtPRCA occurred in one patient. The median number of transfusions was 8 (range: 0-36) between d0 and d100. In 25 patients with high-IHA titer without treatment or treated by other methods to reduce IHA, the need for transfusions was comparable. No difference in the incidence of ptPRCA was observed. Conclusions Selective ABO IA is a feasible, safe, and effective method to reduce IHA before HCT in major ABO incompatibility. No effect on transfusion rate or ptPRCA compared to other strategies could be observed.

Item Type: Journal Article
Creators:
CreatorsEmailORCIDORCID Put Code
Crysandt, MartinaUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Soysal, HaticeUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Jennes, EvaUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Holtick, UdoUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Mrotzek, MatthiasUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Rehnelt, SusanneUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Holderried, Tobias A. W.UNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Wessiepe, MartinaUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Kunter, UtaUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Wilop, StefanUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Silling, GerdaUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Gecht, JudithUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Beier, FabianUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Bruemmendorf, Tim H.UNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Jost, EdgarUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
URN: urn:nbn:de:hbz:38-588456
DOI: 10.1111/ejh.13668
Journal or Publication Title: Eur. J. Haematol.
Volume: 107
Number: 3
Page Range: S. 324 - 333
Date: 2021
Publisher: WILEY
Place of Publication: HOBOKEN
ISSN: 1600-0609
Language: English
Faculty: Unspecified
Divisions: Unspecified
Subjects: no entry
Uncontrolled Keywords:
KeywordsLanguage
BONE-MARROW-TRANSPLANTATION; APLASIA FOLLOWING MAJOR; OUTCOMES; REDUCTION; MISMATCH; IMPACTMultiple languages
HematologyMultiple languages
URI: http://kups.ub.uni-koeln.de/id/eprint/58845

Downloads

Downloads per month over past year

Altmetric

Export

Actions (login required)

View Item View Item